Evidence for Edg-3 receptor-mediated activation of I(K.ACh) by sphingosine-1-phosphate in human atrial cardiomyocytes

Molecular Pharmacology

Volumn 58, Issue 2, 2000, Pages 449-454

  Himmel, Herbert M ^a   Meyer Zu Heringdorf, Dagmar ^b   Graf, Eva ^a   Dobrev, Dobromir ^a   Kortner, Ariane ^a   Schüler, Stephan ^a   Jakobs, Karl H ^b   Ravens, Ursula ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SPHINGOSINE 1 PHOSPHATE; SURAMIN;

ARTICLE; DRUG EFFECT; DRUG POTENCY; GUINEA PIG; HEART MUSCLE CELL; HUMAN; HUMAN CELL; POTASSIUM CURRENT; PRIORITY JOURNAL; SPECIES DIFFERENCE;

EID: 0342322949     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.2.449     Document Type: Article

References (27)

1. Amos GJ, Wettwer E, Metzger F, Li Q, Himmel HM and Ravens U (1996) Differences between outward currents of human atrial and subepicardial ventricular myocytes. J Physiol (Lond) 49:31-50.
2. Ancellin N and Hla T (1999) Differential pharmacological properties and signal transduction of the sphingosine-1-phosphate receptors EDG-1, EDG-3, and EDG-5. J Biol Chem 274:18997-19002.
3. Barry PH (1994) JPCalc, a software package for calculating liquid junction potential corrections in patch-clamp, intracellular, epithelial and bilayer measurements and for correcting junction potential measurements. J Neurosci Methods 51:107-116.
4. + current in guinea-pig atrial myocytes by sphingosine-1-phosphate. J Physiol (Lond) 489:701-707.
5. Bünemann M, Liliom K, Brandts BK, Pott L, Tseng JL, Desiderio DM, Sun G, Miller D and Tigyi G (1996) A novel membrane receptor with high affinity for lysosphin-gomyelin and sphingosine-1-phosphate in atrial myocytes. EMBO J 15:5527-5534.
6. Feng J, Li G, Fermini B and Nattel S (1996) Properties of sodium and potassium currents of cultured adult human atrial myocytes. Am J Physiol 270:H1676-H1686.
7. Goetzl EJ and An S (1998) Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine-1-phosphate. FASEB J 12:1589-1598.
8. Guo J, MacDonell KL and Giles WR (1999) Effects of sphingosine-1-phosphate on pacemaker activity in rabbit sino-atrial node cells. Pfluegers Arch 438:642-648.
9. K ACh) in human atrial myocytes. Naunyn-Schmiedeberg's Arch Pharmacol 361:R106.
10. 2+ current by lysosphingolipids in RINm5F insulinoma cells. Mol Pharmacol 53:862-869.
11. Kon J, Sato K, Watanabe T, Tomura H, Kuwabara A, Kimura T, Tamama K, Ishizuka T, Murata N, Kanda T, Kobayashi I, Ohta H, Ui M and Okajima F (1999) Comparison of intrinsic activities of the putative sphingosine-1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells. J Biol Chem 274:23940-23947.
12. Meyer zu Heringdorf D, Niederdräing N, Neumann E, Fröde R, Lass H, van Koppen CJ and Jakobs KH (1998) Discrimination between plasma membrane and intracellular target sites of sphingosylphosphorylcholine. Eur J Pharmacol 354:113-122.
13. Meyer zu Heringdorf D, van Koppen CJ and Jakobs KH (1997) Molecular diversity of sphingolipid signalling. FEBS Lett 410:34-38.
14. Meyer zu Heringdorf D, van Koppen CJ, Windorfer B, Himmel HM and Jakobs KH (1996) Calcium signalling by G protein-coupled sphingolipid receptors in bovine aortic endothelial cells. Naunyn-Schmiedeberg's Arch Pharmacol 354:397-403.
15. Okamoto H, Takuwa N, Yatomi Y, Gonda K, Shigematsu H and Takuwa Y (1999) EDG-3 is a functional receptor specific for sphingosine-1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG-1 and AGR16. Biochem Biophys Res Commun 260:203-208.
16. Postma FR, Jalink K, Hendeveld T and Moolenaar WH (1996) Sphingosine-1-phosphate rapidly induces rho-dependent neunte retraction: Action through a specific cell surface receptor. EMBO J 15:2388-2395.
17. Spiegel S and Milstien S (1995) Sphingolipid metabolites: Members of a new class of lipid second messengers. J Membr Biol 146:225-237.
18. i coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J Cell Biol 142:229-240.
19. van Brocklyn JR, Tu ZX, Edsall LC, Schmidt RR and Spiegel S (1999) Sphingosine-1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218. J Biol Chem 274:4626-4632.
20. i protein-coupled plasma membrane receptor by sphingosine-1-phosphate. J Biol Chem 271:2082-2087.
21. i protein coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils. Mol Pharmacol 49:956-961.
22. Voogd TE, Vansterkenburg ELM, Wilting J and Janssen LHM (1993) Recent research on the biological activity of suramin. Pharmacol Rev 45:177-203.
23. Wettwer E, Scholtysik G, Schaad A, Himmel HM and Ravens U (1991) Effects of the new class-III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters. J Cardiovasc Pharmacol 17:480-487.
24. Wickman K Nemec J, Gendler SJ and Clapham DE (1998) Abnormal heart rate regulation in GIRK4 knockout mice. Neuron 20:103-114.
25. Yamada M, Inanobe A and Kurachi Y (1998) G protein regulation of potassium ion channels. Pharmacol Rev 50:723-757.
26. Yamamura S, Yatomi Y, Ruan F, Sweeney EA, Hakomori S and Igarashi Y (1997) Sphingosine-1-phosphate regulates melanoma cell motility through a receptor-coupled extracellular action and in a pertussis toxin-insensitive manner. Biochemistry 36:10751-10759.
27. Yatomi Y, Igarashi Y, Yang L, Hisano N, Qi R, Asazuma N, Satoh K, Ozaki Y and Kume S (1997) Sphingosine-1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem 121:969-973